Z.M.D. Medical

Immune-based Cancer Treatment

Health Tech & Life Sciences
Non Active, Sep 2021 ceased to operate
Seed Yavne, Israel Founded 2014
Last updated 2026-06-18
Total raised
$659K
Last: Grant 2018-05
Stage
Seed
Founded
2014
Headcount
6
HQ
Yavne, Israel
Sector
Health Tech & Life Sciences

About

Z.M.D. Medical develops and commercializes a therapeutic remedy designed to treat cancers of all types by using the patients immune system. The companys goal is to produce probiotic preparations to rehabilitate distressed colon microflora in order to eliminate cancer from the immune system and help it recover. Z.M.D. Medicals probiotic ONCARIN consists of a blend of five lyophilized bacteria species, each represented by a single phenotype with maximum oncolytic activity. To preserve the vitality of the bacteria, the drug is enclosed in a capsule that dissolves only after transiting through the stomach with its strong, enteric-coated capsules. The probiotic is designed to prevent the functional state of the immune system from degrading to cancerous conditions and to raise the functional state of a degraded immune system to a normal state, allowing it to eliminate cancer. Z.M.D. Medical is a sister company of Z.M.D. Diagnostics and operates under the Z.M.D. Group (a spin-off of the Tel Hashomer-Sheba TTO).

Funding history · 2 rounds · $659K total

2018-05
Grant $59K
2016-12

Q&A

What is Z.M.D. Medical's primary focus?
Z.M.D. Medical focuses on developing and commercializing immune-based cancer treatments, specifically probiotic preparations designed to rehabilitate distressed colon microflora to eliminate cancer.
When was Z.M.D. Medical founded?
Z.M.D. Medical was founded in August 2014.
What is the status of Z.M.D. Medical?
Z.M.D. Medical is currently inactive, having ceased operations in September 2021.
What is ONCARIN?
ONCARIN is Z.M.D. Medical's probiotic product, consisting of a blend of five lyophilized bacteria species, designed to prevent and reverse the degradation of the immune system to cancerous conditions.
How much funding has Z.M.D. Medical raised in total?
Z.M.D. Medical has raised a total of $659,033.
When was Z.M.D. Medical's last funding round and who participated?
Z.M.D. Medical's last funding round was a Grant in May 2018, with participation from EU Horizon 2020.
How many employees did Z.M.D. Medical have?
Z.M.D. Medical had 1-10 employees.
Who are the co-founders of Z.M.D. Medical?
The co-founders of Z.M.D. Medical are Barak Zigdon, who serves as Co-founder & Board Member, and Mark Gaides, who serves as Co-founder & CSO.

Team · 2

Founder · Co-founder & Board Member
LinkedIn ↗
Founder · Co-founder & CSO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMicroorganisms
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 PatentsVerified

Tags

canceroral-drugschronic-patientspharmaceuticalsmicrobiomeimmunologyoncologydrug-deliverypreventiontherapeuticspharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2014-8
Employees (exact)6
Status reasonNon Active, Sep 2021 ceased to operate